Identification of small molecules that inhibit the histone chaperone Asf1 and its chromatin function
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The eukaryotic genome is packed into chromatin, which is important for the genomic integrity and gene regulation. Chromatin structures are maintained through assembly and disassembly of nucleosomes catalyzed by histone chaperones. Asf1 (anti-silencing function 1) is a highly conserved histone chaperone that mediates histone transfer on/off DNA and promotes histone H3 lysine 56 acetylation at globular core domain of histone H3. To elucidate the role of Asf1 in the modulation of chromatin structure, we screened and identified small molecules that inhibit Asf1 and H3K56 acetylation without affecting other histone modifications. These pyrimidine- 2,4,6-trione derivative molecules inhibited the nucleosome assembly mediated by Asf1 in vitro, and reduced the H3K56 acetylation in HeLa cells. Furthermore, production of HSV viral particles was reduced by these compounds. As Asf1 is implicated in genome integrity, cell proliferation, and cancer, current Asf1 inhibitor molecules may offer an opportunity for the therapeutic development for treatment of diseases.
Abstract
The eukaryotic genome is packed into chromatin, which is important for the genomic integrity and gene regulation. Chromatin structures are maintained through assembly and disassembly of nucleosomes catalyzed by histone chaperones. Asf1 (anti-silencing function 1) is a highly conserved histone chaperone that mediates histone transfer on/off DNA and promotes histone H3 lysine 56 acetylation at globular core domain of histone H3. To elucidate the role of Asf1 in the modulation of chromatin structure, we screened and identified small molecules that inhibit Asf1 and H3K56 acetylation without affecting other histone modifications. These pyrimidine- 2,4,6-trione derivative molecules inhibited the nucleosome assembly mediated by Asf1 in vitro, and reduced the H3K56 acetylation in HeLa cells. Furthermore, production of HSV viral particles was reduced by these compounds. As Asf1 is implicated in genome integrity, cell proliferation, and cancer, current Asf1 inhibitor molecules may offer an opportunity for the therapeutic development for treatment of diseases.
참고문헌 (33)
- Luger K, "Crystal structure of the nucleosome core particle at 2. 8 A resolution", Nature, 389, pp.251~260 (1997)
- Gardner KE, "Operating on chromatin, a colorful language where context matters", J Mol Biol, 409, pp.36~46 (2011)
- West AC, "New and emerging HDAC inhibitors for cancer treatment", J Clin Invest, 124, pp.30~39 (2014)
- Lund K, "DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML", Genome Biol, 15, pp.406~ (2014)
- Helin K, "Chromatin proteins and modifications as drug targets", Nature, 502, pp.480~488 (2013)
- Gurard-Levin ZA, "Histone chaperones: assisting histone traffic and nucleosome dynamics", Annu Rev Biochem, 83, pp.487~517 (2014)
- Kim HJ, "Histone chaperones regulate histone exchange during transcription", EMBO J, 26, pp.4467~4474 (2007)
- Driscoll R, "Yeast Rtt109promotes genome stability by acetylating histone H3 on lysine 56", Science, 315, pp.649~652 (2007)
- Recht J, "Histone chaperone Asf1 is required for histone H3 lysine 56 acetylation, a modification associated with S phase in mitosis and meiosis", Proc Natl Acad Sci U S A, 103, pp.6988~6993 (2006)
- Tsubota T, "Histone H3-K56 acetylation is catalyzed by histone chaperone-dependent complexes", Mol Cell, 25, pp.703~712 (2007)
- Das C, "CBP", p300-mediated acetylation of histone H3 on lysine 56, 2009, pp.459, 113~117
- Han J, "Rtt109 acetylates histone H3 lysine 56 and functions in DNA replication", Science, 315, pp.653~655 (2007)
- Tan Y, "Acetylated histone H3K56 interacts with Oct4 to promote mouse embryonic stem cell pluripotency", Proc Natl Acad Sci U S A, 110, pp.11493~11498 (2013)
- Yuan J, "Histone H3-K56acetylation is important for genomic stability in mammals", Cell Cycle, 8, pp.1747~1753 (2009)
- Battu A, "ASF1A and ATM regulate H3K56-mediated cell-cycle checkpoint recovery in response to UV irradiation", Nucleic Acids Res, 39, pp.7931~7945 (2011)
- Gonzalez-Munoz E, "Cell reprogramming. Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming", Science, 345, pp.822~825 (2014)
- English CM, "Structural basis for the histone chaperone activity of Asf1", Cell, 127, pp.495~508 (2006)
- Agez M, "Structure of the histone chaperone ASF1 bound to the histone H3 C-terminal helix and functional insights", Structure, 15, pp.191~199 (2007)
- Sundriyal S, "New PPARgamma ligands based on barbituric acid: virtual screening, synthesis and receptor binding studies", Bioorg Med Chem Lett, 18, pp.4959~4962 (2008)
- Maquoi E, "Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2, 4, 6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor", Clin Cancer Res, 10, pp.4038~4047 (2004)
- Xia G, "Pyrimidine-2, 4, 6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosis", J Med Chem, 54, pp.2409~2421 (2011)
- Song Y, "Dissecting the roles of the histone chaperones reveals the evolutionary conserved mechanism of transcription-coupled deposition of H3. 3", Nucleic Acids Res, 41, pp.5199~5209 (2013)
- Miller KM, "Human HDAC1and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining", Nat Struct Mol Biol, 17, pp.1144~1151 (2010)
- Tjeertes JV, "Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells", EMBO J, 28, pp.1878~1889 (2009)
- Peng H, "Transcriptional coactivator HCF-1 couples the histone chaperone Asf1b to HSV-1 DNA replication components", Proc Natl Acad Sci U S A, 107, pp.2461~2466 (2010)
- Ambagala AP, "Varicella-zoster virus immediate-early 63 protein interacts with human antisilencing function 1 protein and alters its ability to bind histones h3. 1 and h3. 3", J Virol, 83, pp.200~209 (2009)
- Oh J, "Chromatin assembly on herpes simplex virus 1 DNA early during a lytic infection is Asf1a dependent", J Virol, 86, pp.12313~12321 (2012)
- Wurtele H, "Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy", Nat Med, 16, pp.774~780 (2010)
- Miknis GF, "Development of novel Asf1-H3", H4 inhibitors, 2015, pp.25, 963~968
- Corpet A, "Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer", EMBO J, 30, pp.480~493 (2011)
- Morris GM, "Automated docking with protein flexibility in the design of femtomolar"click chemistry"inhibitors of acetylcholinesterase", J Chem Inf Model, 53, pp.898~906 (2013)
- Park H, "Critical assessment of the automated AutoDock as a new docking tool for virtual screening", Proteins, 65, pp.549~554 (2006)
- Warner MS, "A cell surface protein with herpesvirus entry activity(HveB)confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus", Virology, 246, pp.179~189 (1998)